Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Sugarbud Craft Growers (SUGR) has entered into shares for services agreements with certain service providers
  • Sugarbud will issue a total of 665,020 shares at a deemed price of $0.35 per share in satisfaction of amounts owing totalling $232,757
  • The shares to be issued represent approximately 10 per cent the company’s issued and outstanding shares
  • Sugarbud is a leading craft cannabis company focused on the cultivation and production of cannabis products
  • Sugarbud Craft Growers Corp. (SUGR) opened trading at C$0.35 per share

Sugarbud Craft Growers (SUGR) has entered into shares for services agreements with certain service providers.

Under the terms of the agreements, Sugarbud will issue a total of 665,020 shares at a deemed price of $0.35 per share in satisfaction of amounts owing totalling $232,757.

The shares to be issued represent approximately 10 per cent the company’s issued and outstanding shares.

The transaction is subject to the approval of the TSX Venture Exchange. Shares issued in connection with the agreements will be subject to a statutory 4-month hold period.

Sugarbud is a leading consumer-driven craft cannabis company focused on the cultivation and production of superior, select-batch, craft cannabis products. 

Sugarbud Craft Growers Corp. (SUGR) opened trading at C$0.35 per share.

More From The Market Herald

" Avicanna (TSX:AVCN) partners with Shoppers Drug Mart for cannabis transition

Avicanna (AVCN) has been chosen by Shoppers Drug Mart as its partner to transition its Medical Cannabis by Shoppers business.
1CM Inc.

" 1CM (CSE:EPIC) collaborates with Herbidus Formulation to enter India cannabis industry

1CM (EPIC) announced that it has signed a Business Collaboration Agreement with Herbidus Formulations Pvt Ltd. (the Trost).

" Entourage’s (TSXV:ENTG) CBD-infused ‘functional gum’ joins emerging market

Entourage Health (ENTG) has expanded its medical portfolio with the launch of its new CBD chewing gum.

" Innocan Pharma (CSE:INNO) reports successful efficacy test for vaginal derma product

Innocan Pharma (INNO) has announced successful results from a controlled efficacy test of its vaginal derma product.